Skip to main content
Journal cover image

Doxycycline and the treatment for bullous pemphigoid: what outcomes are most important to our patients?

Publication ,  Journal Article
Cardones, AR; Hall, RP
Published in: Br J Dermatol
November 2017

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Br J Dermatol

DOI

EISSN

1365-2133

Publication Date

November 2017

Volume

177

Issue

5

Start / End Page

1145 / 1147

Location

England

Related Subject Headings

  • Prednisolone
  • Pemphigoid, Bullous
  • Humans
  • Doxycycline
  • Dermatology & Venereal Diseases
  • Anti-Bacterial Agents
  • 3202 Clinical sciences
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Cardones, A. R., & Hall, R. P. (2017). Doxycycline and the treatment for bullous pemphigoid: what outcomes are most important to our patients? Br J Dermatol, 177(5), 1145–1147. https://doi.org/10.1111/bjd.15890
Cardones, A. R., and R. P. Hall. “Doxycycline and the treatment for bullous pemphigoid: what outcomes are most important to our patients?Br J Dermatol 177, no. 5 (November 2017): 1145–47. https://doi.org/10.1111/bjd.15890.
Cardones, A. R., and R. P. Hall. “Doxycycline and the treatment for bullous pemphigoid: what outcomes are most important to our patients?Br J Dermatol, vol. 177, no. 5, Nov. 2017, pp. 1145–47. Pubmed, doi:10.1111/bjd.15890.
Journal cover image

Published In

Br J Dermatol

DOI

EISSN

1365-2133

Publication Date

November 2017

Volume

177

Issue

5

Start / End Page

1145 / 1147

Location

England

Related Subject Headings

  • Prednisolone
  • Pemphigoid, Bullous
  • Humans
  • Doxycycline
  • Dermatology & Venereal Diseases
  • Anti-Bacterial Agents
  • 3202 Clinical sciences
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences